# EDGAR Filing Document

**Accession Number:** 0001342916
**File Stem:** 0000000000-25-009047
**Filing Date:** 2025-8
**Character Count:** 8764
**Document Hash:** 5529c0677523910d64d30aec54082581
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-009047.hdr.sgml**: 20260630

**ACCESSION NUMBER**: 0000000000-25-009047

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250825

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HNO International, Inc.
- **CENTRAL INDEX KEY:** 0001342916
- **STANDARD INDUSTRIAL CLASSIFICATION:** METAL MINING [1000]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 202781289
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 024-12607

**BUSINESS ADDRESS:**
- **STREET 1:** 41558 EASTMAN DRIVE, SUITE B
- **CITY:** MURRIETA
- **STATE:** CA
- **ZIP:** 92562
- **BUSINESS PHONE:** 951-305-8872

**MAIL ADDRESS:**
- **STREET 1:** 41558 EASTMAN DRIVE, SUITE B
- **CITY:** MURRIETA
- **STATE:** CA
- **ZIP:** 92562

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Excoin Ltd.
- **DATE OF NAME CHANGE:** 20210830

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Clenergen Corp
- **DATE OF NAME CHANGE:** 20100317

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CLENERGEN Corp
- **DATE OF NAME CHANGE:** 20090324
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001262463-25-000109

## Text-Extract

```

                                                           August 25, 2025

Donald Owens
President
HNO International, Inc.
41558 Eastman Drive, Suite B
Murrieta, CA 92562

       Re: HNO International, Inc.
           Amendment 2 to Offering Statement on Form 1-A
           Filed August 14, 2025
           File No. 024-12607
Dear Donald Owens:

     We have reviewed your amended offering statement and have the following
comments.

       Please respond to this letter by amending your offering statement and
providing the
requested information. If you do not believe a comment applies to your facts
and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your offering statement and the
information you
provide in response to this letter, we may have additional comments. Unless we
note
otherwise, any references to prior comments are to comments in our August 1,
2025 letter.

Amendment 2 to Offering Statement on Form 1-A
Cover Page

1.     We note your response to prior comment 2. Please revise your disclosure
to discuss
       the First Amended 8% Convertible Promissory Note filed as Exhibit 3.2
and disclose
       that such note was amended to provide that the holder shall have the
right to convert
       the note on the earlier of (a) the day immediately following the
qualification of a
       Regulation A Offering under the Securities Act of 1933, as amended, and
(b) the date
       that is 180 days immediately following the issue date. In addition,
please clarify the
       issue date for the holder's conversion right.
2.     We note footnote 4 to your tabular disclosure states that the number of
shares of
       common stock offered by the selling shareholder was determined by adding
the
       principal amount of the Subject Convertible Note, $45,000, and an
assumed $5,000
 August 25, 2025
Page 2

       of accrued interest thereon, then dividing that sum, $50,000, by the
minimum price in
       the price range, $0.15, for a result of 333,334 shares. It appears that
such calculation
       may involve rounding. If so, please expand your disclosure to explain
that
       calculations are or may be rounded and disclose the rounding convention
being
       utilized.
Offering Summary, page 4

3.     We note your response to comment 4. Please tell us about the additional
12,070,000
       common shares issued since June 18, 2025 that are not included in Note
12 on page F-
       16. Include the dates of issuance, the number of shares and
consideration for which
       securities were issued.
4.     We note your disclosure here and on pages 17 and 33 that there are
95,920,491 shares
       issued and outstanding as of the date of the offering. However, we also
note you
       disclose on page 17 that there are 91,303,824 shares outstanding,
assuming the
       issuance of 333,334 Conversion Shares, and you disclose in Item 4 of
Part I that there
       are 90,970,491 shares outstanding. Please advise or revise.
Selling Shareholder, page 16

5.     We refer you to footnotes (2) and (3) on page 17. Please revise the
number of shares
       outstanding prior to and after this offering to correspond with the
number of shares
       that are disclosed at page 4, Offering Summary.
Business
Our Products, page 19

6.     Please tell us why you have a reasonable basis for providing projections
beyond one
       year. See Item 10(b)(1) of Regulation S-K. We note the $50 million
maximum
       proceeds estimated from this offering exceeds your estimate of the
capital needed for
       construction and other costs for all four products over the projected
3-year period. For
       example, cost estimates in year 1 are approximately $32.75 million and
$12.5 million
       each in years 2 and 3.
7.     The presentation for HyGridTM System and CHRS System include financial
       measures labelled as Cost of Revenues and Net Profit(Loss). Note (1)
discloses that
       Net Profit reflects operating expenses only associated with each
respective system and
       excludes other non-related operating and other expenses incurred by the
Company.
       Based on the disclosure, these two financial measures are not presented
in accordance
       with U.S. GAAP. A registrant may not use titles or descriptions of
non-GAAP
       financial measures that are the same or confusingly similar to titles or
descriptions
       used for GAAP financial measures. To the extent your presentation
continues to
       include non-GAAP financial measures, include a clear definition or
explanation of
       those financial measures, a description of the GAAP financial measure to
which it is
       most directly comparable, and an explanation why the non-GAAP measure
was
       selected instead of a GAAP measure. See Item 10(b)(2)(iv) of Regulation
S-K.
8.     In regards to your HyGridTM System, it appears that you expect customers
to incur
       35,400,000 kilowatts per year ($2,832,000/$0.08 per kilowatt). Please
disclose how
       you determined that amount. Additionally, disclose how you determined
the Cost of
 August 25, 2025
Page 3

       Revenues of $1,002,000.
9.     In regards to the CHRS product, disclose the sale price of $375,000 per
unit in the
       narrative.
10.    We note your response to comment 8. In view of your determination that
the CHRS
       system does not meet the criteria for asset capitalization, revise the
discussion to
       remove reference to owning a built CHRS system that is being marketed.
11.    The disclosure regarding your Hydrogen Carbon Cleaner product appears to
indicate
       that you have the product available to be demonstrated and sold. If this
is not the case,
       please revise your disclosure.
12.    Please disclose how you determined that you could receive $2,500,000 in
revenues
       related to your Electrolyzer Manufacturing Facility.
General

13.    We note your response to prior comment 9 and reissue the comment in
part. We note
       your offering statement continues to include references to your "sole
director."
       However, your executive management disclosure reflects that you have
three
       directors. Please revise or advise.
14.    We note your response to prior comment 12 and reissue the comment. We
note
       you disclose in Item 4 of Part I that you are offering 50,000,000
securities in this
       offering. Please revise Item 4 of Part I to include the total number of
shares being
       qualified under your offering statement, including the 333,334 Selling
Shareholder
       Offered Shares. In addition, please revise Item 4 of Part I to disclose
the portion of the
       aggregate offering price attributable to securities being offered on
behalf of selling
       security holders.
        Please contact Brian McAllister at 202-551-3341 or Kimberly Calder at
202-551-3701
if you have questions regarding comments on the financial statements and
related
matters. Please contact Anuja Majmudar at 202-551-3844 or Karina Dorin at
202-551-3763
with any other questions.

                                                             Sincerely,

                                                             Division of
Corporation Finance
                                                             Office of Energy &
Transportation
cc:   Eric Newlan

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._